[EN] PYRIMIDINE DERIVATIVES AS PGE2 RECEPTOR MODULATORS<br/>[FR] DÉRIVÉS DE PYRIMIDINE UTILISÉS EN TANT QUE MODULATEURS DES RÉCEPTEURS DES PGE2
申请人:IDORSIA PHARMACEUTICALS LTD
公开号:WO2018210988A1
公开(公告)日:2018-11-22
The present invention relates to pyrimidine derivatives of formula (I) wherein (R1)n, R3, R4a, R4b, R5a, R5b and Ar1 are as described in the description and their use in the treatment of cancer by modulating an immune response comprising a reactivation of the immune system in the tumor. The invention further relates to novel benzofurane and benzothiophene derivatives of formula (II) and their use as pharmaceuticals, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as modulators of the prostaglandin 2 receptors EP2 and/or EP4.
申请人:LG CHEM, LTD. 주식회사 엘지화학(120010134563) Corp. No ▼ 110111-2207995BRN ▼107-81-98139
公开号:KR20180008336A
公开(公告)日:2018-01-24
본 명세서는 화합물 및 이를 포함하는 유기 전자 소자에 관한 것이다.
本规范涉及化合物和包含它们的有机电子器件。
NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME
申请人:LG Chem, Ltd.
公开号:EP3305792A1
公开(公告)日:2018-04-11
The present specification provides a nitrogen-containing condensed cyclic compound of chemical formula 1 and an organic light emitting device comprising the same.
Nitrogen-containing condensed cyclic compound and organic light emitting device using same
申请人:LG CHEM, LTD.
公开号:US10347845B2
公开(公告)日:2019-07-09
The present specification provides a nitrogen-containing condensed cyclic compound of chemical formula 1 and an organic light emitting device comprising the same.